Omeprazole and Enterobacter bacteraemia - a phase IV clinical study of FDA data

Summary:

Enterobacter bacteraemia is reported as a side effect among people who take Omeprazole (omeprazole), especially for people who are female, 40-49 old, also take Zolpidem, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Enterobacter bacteraemia when taking Omeprazole. It is created by eHealthMe based on reports of 400,982 people who have side effects when taking Omeprazole from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Enterobacter bacteraemia?

Enterobacter bacteraemia (enterobacter cloacae are nosocomial pathogens that can cause a range of infections such as bacteraemia, lower respiratory tract infection, skin) is found to be associated with 61 drugs and 162 conditions by eHealthMe. Check the latest studies of Enterobacter bacteraemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

400,982 people reported to have side effects when taking Omeprazole.
Among them, 18 people (0.0%) have Enterobacter bacteraemia.

Could Omeprazole cause Enterobacter bacteraemia?

Among these 18 people:

What is the gender of people who have Enterobacter bacteraemia when taking Omeprazole? *

  • female: 66.67 %
  • male: 33.33 %

What is the age of people who have Enterobacter bacteraemia when taking Omeprazole? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.67 %
  • 40-49: 46.67 %
  • 50-59: 20.0 %
  • 60+: 26.67 %

What are other drugs people take besides Omeprazole? *

  1. Xanax: 6 people, 33.33%
  2. Hydrea: 6 people, 33.33%
  3. Noxafil: 6 people, 33.33%
  4. Cytarabine: 6 people, 33.33%
  5. Zolpidem: 6 people, 33.33%
  6. Purinethol: 4 people, 22.22%
  7. Clofarabine: 4 people, 22.22%
  8. Busulfan: 4 people, 22.22%
  9. Cyclosporine: 4 people, 22.22%
  10. Atenolol: 4 people, 22.22%

What are other side effects people have besides Enterobacter bacteraemia? *

  1. Hyperbilirubinaemia (excess of bilirubin in the blood): 7 people, 38.89%
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 6 people, 33.33%
  3. Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 6 people, 33.33%
  4. Diarrhea: 5 people, 27.78%
  5. Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 5 people, 27.78%
  6. Septic Shock (shock due to blood infection): 4 people, 22.22%
  7. Hyperkalemia (damage to or disease of the kidney): 4 people, 22.22%
  8. Toxic Encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances): 4 people, 22.22%
  9. Klebsiella Infection: 4 people, 22.22%
  10. Acute Kidney Failure: 4 people, 22.22%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 22.22%
  2. Erection Problems: 1 person, 5.56%
  3. Anaemia (lack of blood): 1 person, 5.56%
  4. Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 1 person, 5.56%
  5. Constipation: 1 person, 5.56%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%
  7. Dehydration (dryness resulting from the removal of water): 1 person, 5.56%
  8. Diabetes Mellitus Inadequate Control: 1 person, 5.56%
  9. Type 2 Diabetes: 1 person, 5.56%
  10. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and have Enterobacter bacteraemia?

- Check whether Enterobacter bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omeprazole:

Enterobacter bacteraemia treatments and more:

How severe was Enterobacter bacteraemia and when was it recovered:

Expand to all the drugs that have ingredients of omeprazole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterobacter bacteraemia:

Browse all the conditions that are associated with Enterobacter bacteraemia:


How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: